08/19/2022
•2024Viewpoint
Visby Collaborates with Urgent Care Leaders in Scottsdale, AZ
Visby Medical will exhibit at the 14th Annual ConvUrgent Care Symposium. Since 2008, this conference has gathered healthcare leaders into a community around the increasing consumerization of medical care.
14th Annual ConvUrgent Care Symposium
September 6-9, 2022
Hotel Valley Ho
6850 East Main Street
Scottsdale, AZ 85251
The annual ConvUrgent Care Symposium is an opportunity for healthcare leaders to collaborate on the consumerization of medical care and a wonderful reason for Team Visby to pack it up and head down south.
Learn more about the Visby Medical Sexual Health Test
Read more articles & insights
CARB-X awards funding to Visby Medical for gonorrhea, antibiotic susceptibility test
The Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) announced today that it will award biotechnology company Visby Medical of San Jose, California, up to $1.8 million
Visby Medical™ Receives FDA Clearance and CLIA Waiver for second Generation Sexual Health Test for Women
Visby Medical™ announced today that it has received 510(k) clearance and was granted a CLIA waiver from the FDA for its 2nd generation point of
Visby Medical Receives FDA Emergency Use Authorization for Respiratory Health Test for Use in CLIA Waived Settings
Visby Medical announced today that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for its Respiratory Health point of
Visby Medical Expands Series E Round to Over $135 Million
Visby Medical announced today that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for its Respiratory Health point of
